AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3345619 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg plus 72 micrograms alprazolam/hr for a total dose of 1.576 mg in 8 hours
Number of subjects: 4
Study 3345619 — intervention group
Group type: COMPARATOR
Intervention: Placebo (50% propylene glycol injection followed by saline infusion)
Number of subjects: 4
Study 31782027 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional Overeating Questionnaire (EOQ)
Number of subjects: 314
Study 30638420 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily consumption of commercial pasteurized orange juice for 2 months
Number of subjects: 10
Study 28351028 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher protein (HP) formula
Number of subjects: 0
Study 28351028 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower protein (LP) formula
Number of subjects: 0
Study 28351028 — intervention group
Group type: COMPARATOR
Intervention: Breastfed (BF) infants
Number of subjects: 0
Study 26531197 — intervention group
Group type: EXPERIMENTAL
Intervention: Proctored, proficiency‐based, virtual reality robotic suturing curriculum using the da Vinci(®) Skills Simulator™
Number of subjects: 27
Study 26531197 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-participation in training)
Number of subjects: 27
Study 23796193 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 0
Study 23796193 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 0
Study 22120029 — intervention group
Group type: EXPERIMENTAL
Intervention: Meaningful Task Specific Training (MTST)
Number of subjects: 71
Study 19720642 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable polymer DES (rapamycin-eluting)
Number of subjects: 2603
Study 19720642 — intervention group
Group type: COMPARATOR
Intervention: Permanent polymer DES (rapamycin-eluting, Cypher; or everolimus-eluting, Xience)
Number of subjects: 2603
Study 19720642 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable polymer DES
Number of subjects: 2603
Study 19720642 — intervention group
Group type: COMPARATOR
Intervention: Permanent polymer DES
Number of subjects: 2603
Study 17045888 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (40 mg/day)
Number of subjects: 76
Study 17045888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 12580655 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribose supplementation (32 g, 4 x 8-g doses)
Number of subjects: 0
Study 12580655 — intervention group
Group type: COMPARATOR
Intervention: Cellulose (placebo)
Number of subjects: 0
Study 10958029 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT)
Number of subjects: 268
Study 9076407 — intervention group
Group type: EXPERIMENTAL
Intervention: One additional egg per day
Number of subjects: 32
Study 9076407 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional egg)
Number of subjects: 32
Study 8449014 — intervention group
Group type: EXPERIMENTAL
Intervention: Ortho 7/7/7
Number of subjects: 0
Study 8449014 — intervention group
Group type: EXPERIMENTAL
Intervention: Triphasil
Number of subjects: 0
Study 8449014 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 3513540 — intervention group
Group type: EXPERIMENTAL
Intervention: Theo-Dur
Number of subjects: 20
Study 3513540 — intervention group
Group type: EXPERIMENTAL
Intervention: Uniphyl
Number of subjects: 20
Study 3513540 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum theophylline levels
Number of subjects: 20
Study 3513540 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary function tests (PFTs)
Number of subjects: 20
Study 30411316 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise training
Number of subjects: 140
Study 30411316 — intervention group
Group type: COMPARATOR
Intervention: Nonsupervised exercise training
Number of subjects: 140
Study 26210303 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tVNS (daily active stimulation of the left auricle for 26 weeks)
Number of subjects: 20
Study 26210303 — intervention group
Group type: COMPARATOR
Intervention: Sham tVNS (daily sham stimulation for 12 weeks followed by 14 weeks of active stimulation)
Number of subjects: 20
Study 24468255 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-7243 (2,800 BAU Phleum pratense)
Number of subjects: 1501
Study 24468255 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1501
Study 22024002 — intervention group
Group type: EXPERIMENTAL
Intervention: Another SSRI
Number of subjects: 0
Study 22024002 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 0
Study 22024002 — intervention group
Group type: EXPERIMENTAL
Intervention: Another SSRI + cognitive behavior therapy (CBT)
Number of subjects: 0
Study 22024002 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine + CBT
Number of subjects: 0
Study 22024002 — intervention group
Group type: COMPARATOR
Intervention: Control group (school difficulties)
Number of subjects: 0
Study 22024002 — intervention group
Group type: EXPERIMENTAL
Intervention: Adequate depression response
Number of subjects: 0
Study 19729392 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE)-based therapies
Number of subjects: 1403
Study 19729392 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1403
Study 17664205 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (10 mg x kg(‐1) bolus prior to sternotomy, followed by 1 mg x kg(‐1) x hr(‐1) infusion)
Number of subjects: 222
Study 17664205 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 222
Study 17664205 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 222
Study 15377312 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency neurotomy of facet joints C2-C6 ipsilateral to the pain
Number of subjects: 12
Study 15377312 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 12
Study 11432472 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct infusion
Number of subjects: 60
Study 11432472 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafiltration
Number of subjects: 60
Study 11432472 — intervention group
Group type: COMPARATOR
Intervention: Centrifugation
Number of subjects: 60
Study 9683306 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg day(-1))
Number of subjects: 463
Study 9683306 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 463
Study 9683306 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethisterone (2.5 mg day(-1) for 21 days out of 28 for three cycles)
Number of subjects: 463
Study 7851255 — intervention group
Group type: EXPERIMENTAL
Intervention: two-pump protocol
Number of subjects: 58
Study 7851255 — intervention group
Group type: COMPARATOR
Intervention: GIK infusion
Number of subjects: 58
Study 3387033 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone and high-dose metoclopramide (regimen A)
Number of subjects: 28
Study 3387033 — intervention group
Group type: COMPARATOR
Intervention: High-dose dexamethasone and sulpiride (regimen B)
Number of subjects: 28
Study 31524116 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week low-fat diet (<20% energy from fat)
Number of subjects: 0
Study 31524116 — intervention group
Group type: COMPARATOR
Intervention: 8-week high-fat diet (>35% energy from fat)
Number of subjects: 0
Study 31524116 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 0
Study 27720403 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 μg calcitriol
Number of subjects: 120
Study 27720403 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg calcium carbonate + 25 μg calcitriol
Number of subjects: 120
Study 27720403 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 25825344 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-phase acquisition protocol
Number of subjects: 140
Study 25825344 — intervention group
Group type: COMPARATOR
Intervention: Multi-phase acquisition protocol
Number of subjects: 140
Study 22886138 — intervention group
Group type: EXPERIMENTAL
Intervention: Polidocanol (POL) micro-foam injection
Number of subjects: 90
Study 22886138 — intervention group
Group type: COMPARATOR
Intervention: Nd:YAG laser alone
Number of subjects: 90
Study 22886138 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser after POL injection
Number of subjects: 90
Study 21325298 — intervention group
Group type: EXPERIMENTAL
Intervention: Panel of CA 19‐9, ICAM‐1, and OPG
Number of subjects: 333
Study 21325298 — intervention group
Group type: EXPERIMENTAL
Intervention: Panel of CA 19‐9, CEA, and TIMP‐1
Number of subjects: 333
Study 21325298 — intervention group
Group type: EXPERIMENTAL
Intervention: CA19‐9, ICAM‐1, OPG panel
Number of subjects: 333
Study 19281731 — intervention group
Group type: EXPERIMENTAL
Intervention: Losectil DR (Test)
Number of subjects: 24
Study 19281731 — intervention group
Group type: COMPARATOR
Intervention: LOSEC (Reference)
Number of subjects: 24
Study 17885932 — intervention group
Group type: EXPERIMENTAL
Intervention: High trihalomethanes (TTHM) concentrations in drinking water
Number of subjects: 65
Study 17885932 — intervention group
Group type: COMPARATOR
Intervention: Lowest trihalomethanes (TTHM) concentrations in drinking water
Number of subjects: 65
Study 14979860 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher stress in female and young patients
Number of subjects: 322
Study 14979860 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate income, congestive heart failure, high social conflict, low social support, negative coping style
Number of subjects: 322
Study 15265408 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib 25 mg (group RE, n = 15)
Number of subjects: 30
Study 15265408 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group E, n = 15)
Number of subjects: 30
Study 10421125 — intervention group
Group type: EXPERIMENTAL
Intervention: Enflurane administration (0.5% to 2%) for 5 minutes
Number of subjects: 22
Study 10421125 — intervention group
Group type: COMPARATOR
Intervention: Control group (no enflurane administration)
Number of subjects: 22
Study 7554976 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily administration of contraceptive pill for 21 days with a seven-day interruption (intermittent use)
Number of subjects: 900
Study 7554976 — intervention group
Group type: COMPARATOR
Intervention: Daily administration of contraceptive pill without interruption (continuous use)
Number of subjects: 900
Study 7554976 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intermittent and continuous use)
Number of subjects: 900
Study 2404917 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation field size: 5 x 5 cm2 (Group A)
Number of subjects: 87
Study 2404917 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation field size: 6 x 6 cm2 (Group B)
Number of subjects: 87
Study 2404917 — intervention group
Group type: COMPARATOR
Intervention: Historical control
Number of subjects: 87
Study 2404917 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (6 x 6 cm2)
Number of subjects: 87
Study 6158370 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinblastine 0.4 mg/kg every three weeks for four courses
Number of subjects: 78
Study 6158370 — intervention group
Group type: COMPARATOR
Intervention: Vinblastine 0.3 mg/kg every three weeks for four courses
Number of subjects: 78
Study 6158370 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinblastine 0.2 mg/kg plus Adriamycin 50 mg/M2 every three weeks for four courses
Number of subjects: 78
Study 6158370 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance therapy with vinblastine 0.3 mg/kg once a month for 20 months
Number of subjects: 78
Study 6158370 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 78
Study 6158370 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of vinblastine dosages
Number of subjects: 78
Study 31240397 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper-body resistance training (UB)
Number of subjects: 40
Study 31240397 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-body resistance training (LB)
Number of subjects: 40
Study 31240397 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined resistance training (UB + LB)
Number of subjects: 40
Study 31240397 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 40
Study 29407250 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric orthopedists (Group A)
Number of subjects: 90
Study 29407250 — intervention group
Group type: COMPARATOR
Intervention: Non-pediatric orthopedists (Group B)
Number of subjects: 90
Study 29407250 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 90
Study 28115877 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal Morphine (Group M)
Number of subjects: 50
Study 28115877 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal Fentanyl (Group F)
Number of subjects: 50
Study 24581050 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailor-made notched music training (TMNMT) for two hours a day for three months
Number of subjects: 100
Study 24581050 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 100
Study 22190273 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium plus vitamin D supplementation (1,000 mg calcium carbonate plus 400 IU vitamin D(3) daily)
Number of subjects: 32435
Study 22190273 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32435
Study 19685190 — intervention group
Group type: EXPERIMENTAL
Intervention: Kenkou‐tatsujin (KTP) group (KTPG)
Number of subjects: 51
Study 19685190 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 51
Study 19685190 — intervention group
Group type: EXPERIMENTAL
Intervention: KTPG
Number of subjects: 51
Study 19685190 — intervention group
Group type: COMPARATOR
Intervention: CG
Number of subjects: 51
Study 17340636 — intervention group
Group type: EXPERIMENTAL
Intervention: S1 (gadolinium as oral tagging agent and a gadolinium-water mixture for rectal filling)
Number of subjects: 45
Study 17340636 — intervention group
Group type: COMPARATOR
Intervention: S2 (oral barium and water rectally)
Number of subjects: 45
Study 17340636 — intervention group
Group type: EXPERIMENTAL
Intervention: S3 (oral barium and air rectally)
Number of subjects: 45
Study 16336763 — intervention group
Group type: EXPERIMENTAL
Intervention: Two protease inhibitors (saquinavir + nelfinavir)
Number of subjects: 30
Study 16336763 — intervention group
Group type: COMPARATOR
Intervention: One protease inhibitor (saquinavir soft gel capsule)
Number of subjects: 30
Study 12014487 — intervention group
Group type: EXPERIMENTAL
Intervention: Precision tinted lenses
Number of subjects: 21
Study 12014487 — intervention group
Group type: COMPARATOR
Intervention: Control tinted lenses
Number of subjects: 21
Study 10582199 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy
Number of subjects: 39
Study 10582199 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 7602675 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical uvulopalatopharyngoplasty (UPPP) technique
Number of subjects: 68
Study 7602675 — intervention group
Group type: COMPARATOR
Intervention: Modified 'extended UPPP technique' (bilateral resection of the palatopharyngeal muscles)
Number of subjects: 68
Study 28829051 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine transporter (DAT) availability assessed with PET and [11C]PE2I
Number of subjects: 27
Study 28829051 — intervention group
Group type: EXPERIMENTAL
Intervention: Reward-related neural response assessed using fMRI with a modified Monetary Incentive Delay task
Number of subjects: 27
Study 28445374 — intervention group
Group type: EXPERIMENTAL
Intervention: External splint fixation
Number of subjects: 0
Study 28445374 — intervention group
Group type: COMPARATOR
Intervention: Coronal flap plate fixation
Number of subjects: 0
Study 28445374 — intervention group
Group type: COMPARATOR
Intervention: No surgery
Number of subjects: 0
Study 28445374 — intervention group
Group type: COMPARATOR
Intervention: Intraoral approach (no fixation)
Number of subjects: 0
Study 28445374 — intervention group
Group type: COMPARATOR
Intervention: Temporal approach (no fixation)
Number of subjects: 0
Study 26289949 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 680
Study 26289949 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate-amodiaquine (ASAQ)
Number of subjects: 680
Study 24129868 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based Basic Skin Cancer Triage (BSCT) course
Number of subjects: 57
Study 24129868 — intervention group
Group type: COMPARATOR
Intervention: Control web-based course on weight assessment
Number of subjects: 57
Study 21158502 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-words (NWs)
Number of subjects: 4
Study 21158502 — intervention group
Group type: COMPARATOR
Intervention: Real words (RWs)
Number of subjects: 4
Study 18205965 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioural therapy (CBT)
Number of subjects: 301
Study 18205965 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 301
Study 18205965 — intervention group
Group type: EXPERIMENTAL
Intervention: Group CBT (Lewinsohn's Coping with Depression Course)
Number of subjects: 301
Study 16573870 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 14626395 — intervention group
Group type: EXPERIMENTAL
Intervention: Preincisional periportal infiltration with 20 mL of ropivacaine (10 mg/mL)
Number of subjects: 190
Study 14626395 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 190
Study 10711915 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline maintenance therapy (plasma levels 60-150 ng/mL) for up to 2 years
Number of subjects: 58
Study 10711915 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 9352864 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (0.25 IU/kg body wt)
Number of subjects: 20
Study 9352864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8412261 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefamandole
Number of subjects: 1641
Study 8412261 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 1641
Study 8412261 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime
Number of subjects: 1641
Study 8412261 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control mentioned)
Number of subjects: 1641
Study 3082103 — intervention group
Group type: EXPERIMENTAL
Intervention: Netilmicin plus azlocillin
Number of subjects: 42
Study 3082103 — intervention group
Group type: COMPARATOR
Intervention: Netilmicin plus ticarcillin
Number of subjects: 42
Study 3082103 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 42
Study 31442298 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor-based DAPT
Number of subjects: 44
Study 31442298 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor-monotherapy
Number of subjects: 44
Study 29041823 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile cues to the hip muscles
Number of subjects: 10
Study 29041823 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal cues
Number of subjects: 10
Study 29041823 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile cues
Number of subjects: 10
Study 29041823 — intervention group
Group type: COMPARATOR
Intervention: Control (no cue)
Number of subjects: 10
Study 29095942 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E therapy
Number of subjects: 314
Study 29095942 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 314
Study 29095942 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 314
Study 29095942 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 314
Study 29095942 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall analysis
Number of subjects: 314
Study 29095942 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal analysis
Number of subjects: 314
Study 25578146 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening group (10,411 women)
Number of subjects: 20904
Study 25578146 — intervention group
Group type: COMPARATOR
Intervention: Control group (10,949 women)
Number of subjects: 20904
Study 25578146 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening group
Number of subjects: 20904
Study 25578146 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20904
Study 22886852 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine/scopolamine mixture at 12.10/9.50 µg kg(‐1) body mass (BM)
Number of subjects: 20
Study 22886852 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine/scopolamine mixture at 0.37/0.29 and 1.22/0.95 µg kg(‐1) BM
Number of subjects: 20
Study 22886852 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine/scopolamine mixture at 0.12/0.10 µg kg(‐1) BM
Number of subjects: 20
Study 22886852 — intervention group
Group type: COMPARATOR
Intervention: Atropine/scopolamine mixture (various doses)
Number of subjects: 20
Study 21982669 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac-derived biomarkers (subset of first 1,000 patients enrolled)
Number of subjects: 3847
Study 21982669 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior heart failure
Number of subjects: 3847
Study 21982669 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 3847
Study 21982669 — intervention group
Group type: EXPERIMENTAL
Intervention: Log urine protein/creatinine ratio
Number of subjects: 3847
Study 21982669 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein ≥6.6 mg/L
Number of subjects: 3847
Study 21982669 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal electrocardiogram
Number of subjects: 3847
Study 21982669 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac-derived biomarkers
Number of subjects: 3847
Study 18488436 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg daily
Number of subjects: 91
Study 18488436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 16343498 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol 400 mcg
Number of subjects: 100